Patents by Inventor Gene H. Zaid

Gene H. Zaid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
    Patent number: 10532043
    Abstract: Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: January 14, 2020
    Assignee: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Thomas W. Burgoyne
  • THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF
    Publication number: 20200000779
    Abstract: Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.
    Type: Application
    Filed: August 15, 2019
    Publication date: January 2, 2020
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Thomas W. Burgoyne
  • Therapeutics compositions containing harmine and isovanillin components, and methods of use thereof
    Patent number: 10507200
    Abstract: Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: December 17, 2019
    Assignee: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Thomas W. Burgoyne
  • THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF
    Publication number: 20190365724
    Abstract: Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.
    Type: Application
    Filed: August 15, 2019
    Publication date: December 5, 2019
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Thomas W. Burgoyne
  • THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF
    Publication number: 20190365725
    Abstract: Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.
    Type: Application
    Filed: August 15, 2019
    Publication date: December 5, 2019
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Thomas W. Burgoyne
  • Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
    Patent number: 10471049
    Abstract: Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: November 12, 2019
    Assignee: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Thomas W. Burgoyne
  • THYMOQUINONE/HARMALINE AND RELATED REACTION PRODUCTS
    Publication number: 20190315742
    Abstract: New compositions of matter useful for the treatment of human diabetes and cancers comprise the reaction products of thymoquinone and harmaline or harmaline-like compounds, such as ?-carboline compounds, and the derivatives, solvates, prodrugs, isomers, and tautomers of such compounds.
    Type: Application
    Filed: April 10, 2019
    Publication date: October 17, 2019
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Cameron E. West
  • NUTRITIONAL SUPPLEMENT
    Publication number: 20190269166
    Abstract: Nutritional supplements comprising individual quantities of turmeric, Peganum harmala, and Arum palaestinum are provided, which promote several aspects of human health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum, and the supplements may contain additional beneficial ingredients, such as ?-sitosterol, vanillin, garlic, and Vitamin C.
    Type: Application
    Filed: May 22, 2019
    Publication date: September 5, 2019
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Larry D. Crow
  • NUTRITIONAL SUPPLEMENT
    Publication number: 20190261667
    Abstract: Nutritional supplements comprising individual quantities of turmeric, Peganum harmala, and Arum palaestinum are provided, which promote several aspects of human health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum, and the supplements may contain additional beneficial ingredients, such as ?-sitosterol, vanillin, garlic, and Vitamin C.
    Type: Application
    Filed: August 28, 2018
    Publication date: August 29, 2019
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Larry D. Crow
  • NUTRITIONAL SUPPLEMENT FOR MAMMALS
    Publication number: 20190262416
    Abstract: Mammalian nutritional supplements comprising individual quantities of turmeric, Peganum harmala, and Arum palaestinum are provided, which promote several aspects of human health, and canine health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum, and the supplements may contain additional beneficial ingredients, such as ?-sitosterol, vanillin, garlic, and Vitamin C.
    Type: Application
    Filed: February 20, 2019
    Publication date: August 29, 2019
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Larry D. Crow, Robert Preston Moore, Rachel Elizabeth Ropp
  • THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF
    Publication number: 20190231756
    Abstract: Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.
    Type: Application
    Filed: December 7, 2018
    Publication date: August 1, 2019
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Thomas W. Burgoyne
  • Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof
    Patent number: 10092550
    Abstract: Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: October 9, 2018
    Assignee: Ions Pharmaceutical S.à r.l.
    Inventors: Gene H. Zaid, Thomas W. Burgoyne
  • Corrosion inhibitors for drilling fluid brines
    Patent number: 10094203
    Abstract: Improved corrosion inhibitors for well brines include a phosphonate or salts thereof, and a gluconic acid or salts thereof. The inhibitors are normally injected downhole into the brines. The most preferred phosphonates are amine polyphosphonates, used in combination with alkali metal salts of gluconic acid.
    Type: Grant
    Filed: October 29, 2015
    Date of Patent: October 9, 2018
    Assignee: CES TECHNOLOGY S.À R.L.
    Inventors: Gene H. Zaid, David P. Horton, Kim Brashear
  • THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF
    Publication number: 20180078535
    Abstract: Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.
    Type: Application
    Filed: November 29, 2017
    Publication date: March 22, 2018
    Applicant: Ions Pharmaceutical S.à r.l.
    Inventors: Gene H. Zaid, Thomas W. Burgoyne
  • Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
    Patent number: 9907786
    Abstract: Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: March 6, 2018
    Assignee: Ions Pharmaceutical S.à r.l.
    Inventors: Gene H. Zaid, Thomas W. Burgoyne
  • THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF
    Publication number: 20170216222
    Abstract: Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.
    Type: Application
    Filed: April 13, 2017
    Publication date: August 3, 2017
    Applicant: Ions Pharmaceutical S.à r.l.
    Inventors: Gene H. Zaid, Thomas W. Burgoyne
  • Emulsified polyol acrylate polymeric emulsion breakers
    Patent number: 9701830
    Abstract: Improved emulsion breakers in the form of polyol acrylate polymers in water/oil emulsions have relatively high polymer contents and low inversion viscosities. The emulsion breakers can be prepared by mixing together acrylate monomer, polyol, water, liquid petroleum product, and emulsifier, followed by homogenization of the mixture; the latter is then subjected to free radical polymerization to polymerize the polyol and monomer in situ within the mixture.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: July 11, 2017
    Assignee: Jacam Chemical Company 2013, LLC
    Inventors: David Jay Rose, Thomas Joseph Fortune, Thomas W. Burgoyne, Kim Brashear, Beth Ann Wolf, Gene H. Zaid
  • Poly alkanolamine emulsion breakers
    Patent number: 9701791
    Abstract: Poly alkanolamines formed as the reaction products of secondary or tertiary alkanolamines, C8-C24 fatty acids, and shorter chain organic acids are provided, which serve as excellent petroleum/water emulsion breakers for water-in-oil emulsions and reverse oil-in-water emulsions. The polymers are preferably prepared using a reaction mixture of triethanolamine, tall oil fatty acids, and acetic acid.
    Type: Grant
    Filed: August 18, 2016
    Date of Patent: July 11, 2017
    Assignee: Jacam Chemical Company 2013, LLC
    Inventors: David Jay Rose, Thomas Joseph Fortune, Thomas W. Burgoyne, Kim Brashear, Beth Ann Wolf, Gene H. Zaid
  • THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF
    Publication number: 20170105975
    Abstract: Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.
    Type: Application
    Filed: October 28, 2016
    Publication date: April 20, 2017
    Applicant: Ions Pharmaceutical S.à r.l.
    Inventors: Gene H. Zaid, Thomas W. Burgoyne
  • THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF
    Publication number: 20170105976
    Abstract: Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.
    Type: Application
    Filed: October 28, 2016
    Publication date: April 20, 2017
    Applicant: Ions Pharmaceutical S.à r.I.
    Inventors: Gene H. Zaid, Thomas W. Burgoyne